Organization: Austin Research Institute

Trillium Therapeutics acquires Australia’s Arthron

Trillium Therapeutics Inc, Toronto, has acquired Arthron Ltd Pty, a subsidiary of Prima Biomed Ltd, Melbourne Australia. Trillium will provide Prima with an upfront cash payment and shares representing 5.6% of its outstanding share capital. Prima will also be eligible to receive additional shares if certain business development and clinical milestones are met. Arthron owns…